Beltropin 36 IU - Beligas Pharmaceuticals

Historically, HGH was extracted from human pituitary glands but was later linked to Creutzfeldt-Jakob Disease (CJD), leading to a ban in 1985 on cadaver-sourced HGH. The introduction of synthetic somatropin offered a safer alternative, free from biological contamination, allowing HGH treatments to continue without the risks associated with cadaver-derived hormones​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Beltropin 36 IU by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.